Neumora Revenue and Competitors
Estimated Revenue & Valuation
- Neumora's estimated annual revenue is currently $24.8M per year.
- Neumora's estimated revenue per employee is $155,000
Employee Data
- Neumora has 160 Employees.
- Neumora grew their employee count by 7% last year.
Neumora's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-founder, Executive Chairman | Reveal Email/Phone |
2 | VP Clinical Operations | Reveal Email/Phone |
3 | VP, Program Leadership | Reveal Email/Phone |
4 | VP, Head Translational Science | Reveal Email/Phone |
5 | VP, Head Corporate Development | Reveal Email/Phone |
6 | VP Asset Leadership | Reveal Email/Phone |
7 | VP, Discovery Chemistry | Reveal Email/Phone |
8 | VP, Head IP | Reveal Email/Phone |
9 | VP, Associate General Counsel | Reveal Email/Phone |
10 | SVP, Business Technology & Digital Health | Reveal Email/Phone |
Neumora Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Neumora?
Brain diseases are not “one-size-fits-all” - but the industry currently treats them that way. At Neumora, our mission is to transform the treatment and patient outcomes for brain diseases – with precision. Our proprietary toolbox of state-of-the-art neural network technologies is built to integrate multiple types of data across genomics, imaging, electroencephalogram (EEG), digital and clinical domains to create Data Biopsy Signatures™ that map the underlying disease mechanisms to Precision Phenotypes™ that identify distinct patient subtypes. Through this approach, we have the ability to develop and match the right therapeutic to the right patient populations for more targeted treatments. Together, we are committed to creating a new era in modern precision medicine. Brain disease doesn’t wait. And neither will we.
keywords:N/AN/A
Total Funding
160
Number of Employees
$24.8M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Neumora News
Neumora's second clinical-phase program is a V1aR antagonist that is in phase 1 development as a treatment for anxiety disorders. Having emerged...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $24.8M | 160 | 7% | N/A |
#2 | $17.9M | 163 | 5% | N/A |
#3 | $33.3M | 168 | 7% | N/A |
#4 | $18.9M | 172 | 15% | N/A |
#5 | $26.8M | 173 | 30% | N/A |